Are expensive vaccines the best investment in lower-middle income countries?

Lone Simonsen, Maarten van Wijhe, Robert J. Taylor

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalThe Lancet Global Health
ISSN2214-109X
Publication statusAccepted/In press - 2019

Bibliographical note

Invited commentary

Cite this

@article{c6f135888b3c41b18ea02366f163965c,
title = "Are expensive vaccines the best investment in lower-middle income countries?",
author = "Lone Simonsen and Wijhe, {Maarten van} and Taylor, {Robert J.}",
note = "Invited commentary",
year = "2019",
language = "English",
journal = "The Lancet Global Health",
issn = "2214-109X",
publisher = "TheLancet Publishing Group",

}

Are expensive vaccines the best investment in lower-middle income countries? / Simonsen, Lone; Wijhe, Maarten van; Taylor, Robert J.

In: The Lancet Global Health, 2019.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Are expensive vaccines the best investment in lower-middle income countries?

AU - Simonsen, Lone

AU - Wijhe, Maarten van

AU - Taylor, Robert J.

N1 - Invited commentary

PY - 2019

Y1 - 2019

M3 - Journal article

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

ER -